Tag Archives: Dr Charles Lapp
Managing COVID-19 post viral fatigue syndrome
Managing COVID-19 post viral fatigue syndrome, by Charles W Lapp and Joseph F John in Fatigue: Biomedicine, Health & Behavior, Feb 22, 2021 Article abstract: In online surveys, over 50% of persons who contract COVD-19 experience symptoms lasting longer than … Continue reading
Ampligen – AIM doses first ‘long hauler’ patient in trial of post-Covid-19 infection
Clinical Trial Arena: AIM doses first ‘long hauler’ patient in trial of post-Covid-19 infection, 7 January 2021 AIM ImmunoTech has dosed its first Covid-19 ‘long hauler’ patient in the active AMP-511 Expanded Access Program (EAP) with the Ampligen (rintatolimod) … Continue reading
Estimating prevalence, demographics & costs of ME/CFS using large scale medical claims data & Machine Learning (US)
Estimating prevalence, demographics and costs of ME/CFS using large scale medical claims data and machine learning, by Ashley Valdez, Elizabeth E. Hancock, Seyi Adebayo, David Kiernicki, Daniel Proskauer, John R. Attewell, Lucinda Bateman, Alfred DeMaria, Jr, Charles W. Lapp, Peter … Continue reading
Initiating care of a patient with ME/CFS
Initiating care of a patient with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), by Charles W. Lapp in Front. Pediatr., [Published 23 January 2019] Article abstract: This paper introduces the primary care physician to the unique and challenging aspects of initially … Continue reading
Mast Cell Activation may underlie CFS
Medscape blog post, 13 March 2018, by Miriam Tucker: Mast Cell Activation may underlie ‘Chronic Fatigue Syndrome’ Mast cell activation syndrome (MCAS) may be an overlooked yet potentially treatable contributor to the symptoms of chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS), say … Continue reading
Nausea and sickness: non-drug options
MEA blog post, 29 June 2016: Dr Charles Shepherd reports on two non-drug options for nausea and sickness in ME/CFS New guidance from the Royal College of Obstetricians and Gynaecologists adds further weight to the fact that two non-drug options … Continue reading
Cognition and ME/CFS
Health Rising’s Cognition Resource hub contains 3 new papers with useful information about cognitive problems in ME. Cognition and Chronic Fatigue Syndrome (ME/CFS): Key Findings and Seminal Papers- The what, where and why of the thinking problems found in ME/CFS, by … Continue reading
Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)
Research abstract: Background: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a debilitating disease of unknown pathogenesis consisting of a variety of flu-like symptoms including severe fatigue. Initial analysis of the use of rintatolimod (Poly I: Poly C12U), a selective TLR3 agonist, … Continue reading
